within Pharmacolibrary.Drugs.ATC.D;

model D07XB30
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0016666666666666668,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D07XB30</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>A topical preparation combining a potent corticosteroid (betamethasone) with an aminoglycoside antibiotic (gentamicin) for the treatment of inflammatory skin disorders with suspected or confirmed secondary bacterial infection; currently approved and available in several countries.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for betamethasone and gentamicin in topical combination creams in healthy adult subjects, based on published single-compound dermal absorption data; no direct clinical PK model for combination product available.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D07XB30;
